Boardminder

    Phyllis R. Yale

    2 boards
    Needs Review
    As of 8/31/2026

    0.34

    Boardminder Score™

    Bottom 47% of 4,262 directors

    Lower scoreHigher score

    9.2

    Avg Tenure (yrs)

    Shorter tenure than 36% of directors

    ShorterLonger

    $320K

    Total Compensation

    Lower than 20% of 430 2-seat directors

    LowerHigher
    Board Seats Breakdown
    Bristol-Myers Squibb Company
    BMY
    F500 #96
    Director
    Healthcare
    Seat Score
    0.33
    Tenure
    7.7 yrs
    Compensation
    $140K
    Excess Return
    -94.3%
    DaVita Inc.
    DVA
    F500 #324
    Director
    Needs Review
    Seat Score
    0.34
    Tenure
    10.7 yrs
    Compensation
    $180K
    Excess Return
    -54.6%